Yogesh Kumar

Dr. Yogesh Kumar


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
NSNandini Sharma
Nandini Sharma
VBVijay Bahadur
Vijay Bahadur
USUpendra Sharma
Upendra Sharma
DSDebasmita Saha
Debasmita Saha
ZLZhenghua Li
Zhenghua Li
EEErik Van Der Eycken
Erik Van Der Eycken

1 January 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
VBVijay Bahadur
Vijay Bahadur
DMDaniela Mastronicola
Daniela Mastronicola
HTHemandra Kumar Tiwari
Hemandra Kumar Tiwari
YKYogesh Kumar
Yogesh Kumar
Micol FalabellaMicol Falabella
Micol Falabella
BSBrajendra Kumar Singh
Brajendra Kumar Singh
Giardia intestinalis is the most frequent protozoan agent of intestinal diseases worldwide. Though commonly regarded as an anaerobic pathogen, it preferentially colonizes the fairly oxygen-rich mucosa of the proximal small intestine. Therefore, when testing new potential antigiardial drugs, O 2 should be taken into account, since it also reduces the efficacy of metronidazole, the gold standard drug against giardiasis. In this study, 46 novel chalcones were synthesized by microwave-assisted Claisen-Schmidt condensation, purified, characterized by high-resolution mass spectrometry, 1 H and 13 C nuclear magnetic resonance, and infrared spectroscopy, and tested for their toxicity against G. intestinalis under standard anaerobic conditions. As a novel approach, compounds showing antigiardial activity under anaerobiosis were also assayed under microaerobic conditions, and their selectivity against parasitic cells was assessed in a counterscreen on human epithelial colorectal adenocarcinoma cells. Among the tested compounds, three [30(a), 31(e), and 33] were more effective in the presence of O 2 than under anaerobic conditions and killed the parasite 2 to 4 times more efficiently than metronidazole under anaerobiosis. Two of them [30(a) and 31(e)] proved to be selective against parasitic cells, thus representing potential candidates for the design of novel antigiardial drugs. This study highlights the importance of testing new potential antigiardial agents not only under anaerobic conditions but also at low, more physiological O 2 concentrations.

15 May 2025 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
GGGarv Gupta
Garv Gupta
KRKhushi Ray
Khushi Ray
PSPriyanshu Singh
Priyanshu Singh
PMPoonam Mothsra
Poonam Mothsra
IEIiya Efimov
Iiya Efimov
YKYogesh Kumar
Yogesh Kumar

1 August 2024 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AJAkanksha Jain
Akanksha Jain
RKRajesh Kumar
Rajesh Kumar
PMPoonam Mothsra
Poonam Mothsra
ASAtul Kumar Sharma
Atul Kumar Sharma
ASAnil Kumar Singh
Anil Kumar Singh
YKYogesh Kumar
Yogesh Kumar
: Tuberculosis (TB) is one of the leading causes of death world-wide after AIDS. It infects around one-third of global population and approximately two million people die annually from this disease because it is a very contagious disease spread by Mycobacterium tuberculosis. The increasing number of drug-resistant strains and the failure of conventional treatments against this strain are the challenges of the coming decades. New therapeutic techniques aim to confirm cure without deterioration, to reduce deaths, contagions and the formation of drug-resistant strains. A plethora of new diagnostic tests are available to diagnose the active tuberculosis, screen latent M. tuberculosis infection, and to identify drug-resistant strains of M. tuberculosis. When effective prevention strategies do not prevail, high rates of early case detection and successive cures to control TB emergence would not be possible. In this review, we discussed the structural features of M. tuberculosis, Multi drug resistance tuberculosis (MDR-TB), extremely drug-resistant tuberculosis (XDR-TB), the mechanism of M. tuberculosis infection, the mode of action of first and second-line antitubercular drugs, the mechanism of resistance to the existing drugs, compounds in preclinical and clinical trial and drugs presently available for the treatment of tuberculosis. Moreover, the new diagnostic techniques to detect M. Tuberculosis are also discussed in this review.

1 January 2018 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
Brijesh RathiBrijesh Rathi
Brijesh Rathi
YKYogesh Kumar
Yogesh Kumar
SKSumit Kumar
Sumit Kumar
PSPoonam Singh
Poonam Singh

10 January 2019 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
Brijesh RathiBrijesh Rathi
Brijesh Rathi
YKYogesh Kumar
Yogesh Kumar
SKSumit Kumar
Sumit Kumar
PSPoonam Singh
Poonam Singh